caprylates has been researched along with sorbitan monostearate in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (sorbitan monostearate) | Trials (sorbitan monostearate) | Recent Studies (post-2010) (sorbitan monostearate) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 133 | 3 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowicz, SM; Clemes Külkamp-Guerreiro, I; da Rosa Monte Machado, G; Domingues Bianchin, M; Meneghello Fuentefria, A; Pippi, B; Raffin Pohlmann, A; Stanisçuaski Guterres, S | 1 |
1 other study(ies) available for caprylates and sorbitan monostearate
| Article | Year |
|---|---|
Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caprylates; Delayed-Action Preparations; Drug Compounding; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Genes, MDR; Hexoses; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nanoparticles; Palmitates; Particle Size; Triglycerides; Verapamil | 2019 |